76 related articles for article (PubMed ID: 7838239)
1. Routine vaccination in HIV-infected patients: a review.
Borleffs JC; Schneider MM
Neth J Med; 1994 Dec; 45(6):244-9. PubMed ID: 7838239
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy of vaccination against hepatitis B in adult with HIV infection].
Kalinowska-Nowak A; Bociaga-Jasik M; Garlicki A; Mach T
Przegl Epidemiol; 2007; 61(2):339-47. PubMed ID: 17956052
[TBL] [Abstract][Full Text] [Related]
3. Clinical experience of the 23-valent capsular polysaccharide pneumococcal vaccination in HIV-1-infected patients receiving highly active antiretroviral therapy: a prospective observational study.
Hung CC; Chen MY; Hsieh SM; Hsiao CF; Sheng WH; Chang SC
Vaccine; 2004 May; 22(15-16):2006-12. PubMed ID: 15121313
[TBL] [Abstract][Full Text] [Related]
4. Long-term persistence of vaccination and HAART to human immunodeficiency virus (HIV).
Boström AC; Hejdeman B; Matsuda R; Fredriksson M; Fredriksson EL; Bratt G; Sandström E; Wahren B
Vaccine; 2004 Apr; 22(13-14):1683-91. PubMed ID: 15068851
[TBL] [Abstract][Full Text] [Related]
5. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis.
Nachman S; Gona P; Dankner W; Weinberg A; Yogev R; Gershon A; Rathore M; Read JS; Huang S; Elgie C; Hudgens K; Hughes W
Pediatrics; 2005 Apr; 115(4):e488-94. PubMed ID: 15772172
[TBL] [Abstract][Full Text] [Related]
6. Response of human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy to vaccination with 23-valent pneumococcal polysaccharide vaccine.
Rodriguez-Barradas MC; Alexandraki I; Nazir T; Foltzer M; Musher DM; Brown S; Thornby J
Clin Infect Dis; 2003 Aug; 37(3):438-47. PubMed ID: 12884170
[TBL] [Abstract][Full Text] [Related]
7. Predictors of immunity after hepatitis A vaccination in HIV-infected persons.
Overton ET; Nurutdinova D; Sungkanuparph S; Seyfried W; Groger RK; Powderly WG
J Viral Hepat; 2007 Mar; 14(3):189-93. PubMed ID: 17305885
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B vaccine: a seven-year study of adherence to the immunization guidelines and efficacy in HIV-1-positive adults.
Bailey CL; Smith V; Sands M
Int J Infect Dis; 2008 Nov; 12(6):e77-83. PubMed ID: 18723381
[TBL] [Abstract][Full Text] [Related]
9. T-cell vaccination against anti-CD4 autoimmunity in HIV-1 infected patients.
Abulafia-Lapid R; Bentwich Z; Keren-Zur Y; Cohen IR; Atlan H
J Clin Virol; 2004 Dec; 31 Suppl 1():S48-54. PubMed ID: 15567094
[TBL] [Abstract][Full Text] [Related]
10. Antibody response to an eight-site intradermal rabies vaccination in patients infected with Human Immunodeficiency Virus.
Sirikwin S; Likanonsakul S; Waradejwinyoo S; Pattamadilok S; Kumperasart S; Chaovavanich A; Manatsathit S; Malerczyk C; Wasi C
Vaccine; 2009 Jul; 27(32):4350-4. PubMed ID: 19487057
[TBL] [Abstract][Full Text] [Related]
11. Influenza virus-stimulated generation of anti-human immunodeficiency virus (HIV) activity after influenza vaccination in HIV-infected individuals and healthy control subjects.
Pinto LA; Blazevic V; Anderson SA; Venzon DJ; Trubey CM; Rowe T; Katz JM; Liewehr D; Dolan MJ; Shearer GM
J Infect Dis; 2001 Apr; 183(7):1000-8. PubMed ID: 11237823
[TBL] [Abstract][Full Text] [Related]
12. Immunological and virological efficacy of a therapeutic immunization combined with interleukin-2 in chronically HIV-1 infected patients.
Lévy Y; Gahéry-Ségard H; Durier C; Lascaux AS; Goujard C; Meiffrédy V; Rouzioux C; El Habib R; Beumont-Mauviel M; Guillet JG; Delfraissy JF; Aboulker JP;
AIDS; 2005 Feb; 19(3):279-86. PubMed ID: 15718838
[TBL] [Abstract][Full Text] [Related]
13. [Proposals for guidelines for vaccination of adults infected with HIV-1 in the Czech Republic].
Jilich D; Machala L; Rozsypal H; Aster V; Stanková M
Klin Mikrobiol Infekc Lek; 2008 Apr; 14(2):60-6. PubMed ID: 18756438
[TBL] [Abstract][Full Text] [Related]
14. T-cell vaccination against anti-CD4 autoimmunity in HIV-1 subtypes B and C-infected patients--an extended open trial.
Abulafia-Lapid R; Mayan S; Bentwich Z; Keren-Zur Y; Avbramovitz Y; Cohen IR; Atlan H
Vaccine; 2005 Mar; 23(17-18):2149-53. PubMed ID: 15755585
[TBL] [Abstract][Full Text] [Related]
15. Pertussis booster vaccination in HIV-infected children receiving highly active antiretroviral therapy.
Abzug MJ; Song LY; Fenton T; Nachman SA; Levin MJ; Rosenblatt HM; Pelton SI; Borkowsky W; Edwards KM; Peters J;
Pediatrics; 2007 Nov; 120(5):e1190-202. PubMed ID: 17938165
[TBL] [Abstract][Full Text] [Related]
16. [Which are the vaccines that human immunodeficiency virus infected patients must receive?].
Valencia Ortega ME; González Lahoz JM
An Med Interna; 1998 Aug; 15(8):439-42. PubMed ID: 9780428
[TBL] [Abstract][Full Text] [Related]
17. Poor responses to recombinant HBV vaccination in patients with HIV infection.
Pasricha N; Datta U; Chawla Y; Singh S; Arora SK; Sud A; Minz RW; Saikia B; Singh H; James I; Sehgal S
Trop Gastroenterol; 2005; 26(4):178-82. PubMed ID: 16737046
[TBL] [Abstract][Full Text] [Related]
18. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
[TBL] [Abstract][Full Text] [Related]
19. Pneumonia in HIV-infected patients in the HAART era: incidence, risk, and impact of the pneumococcal vaccination.
López-Palomo C; Martín-Zamorano M; Benítez E; Fernández-Gutiérrez C; Guerrero F; Rodríguez-Iglesias M; Girón-González JA
J Med Virol; 2004 Apr; 72(4):517-24. PubMed ID: 14981752
[TBL] [Abstract][Full Text] [Related]
20. Immunological response in HIV-positive patients vaccinated against tick-borne encephalitis.
Panasiuk B; Prokopowicz D; Panasiuk A
Infection; 2003 Jan; 31(1):45-6. PubMed ID: 12590332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
